Heart health and antibiotics safety: Z-Pak update
Azithromycin, often sold in a five-day dose known as a Z-Pak, is part of the macrolide class of antibiotics, which also includes erythromycin. Other antibiotics from this class also pose similar risks for those with heart disease risk factors, according to Dr. Deepak Bhatt, an interventional cardiologist and associate professor at Harvard Medical School.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
